Implication of OPRM1 A118G Polymorphism in Opioids Addicts in Pakistan: In Vitro and In Silico Analysis

Overview

Journal J Mol Neurosci

Specialties Molecular Biology
Neurology

Date 2018 Jul 24

PMID 30033503

Citations 8

Authors

Madiha Ahmed

Ihsan Ul Haq

Muhammad Faisal

Durdana Waseem

Malik Mumtaz Taqi

Affiliations

Soon will be listed here.

Abstract

Single nucleotide polymorphism in OPRM1 gene is associated with hedonic and reinforcing consequences of opioids. Risk and protective alleles may vary in different populations. One hundred healthy controls and 100 opioids (predominantly heroin) addicts from Pakistani origin were genotyped for A118G (N40D) polymorphism in OPRM1. Structural and functional impact of the polymorphism on encoded protein was predicted by in silico analysis. Results show significant association between homozygous GG genotype and opioid addiction in Pakistani population (p value = 0.016). In silico analysis by SIFT (TI = 0.61), PolyPhen (PISC = 0.227), PANTHER (subPSEC = -1.7171), and SNP effect predicted this SNP benign for encoded protein. Superimposing wild-type and mutated proteins by MODELLER shows no change (RMSD = 0.1) in extracellular ligand binding domain of μ-opioid receptor. However, Haploreg and RegulomeDB predicted OPRM1 gene repression by chromatin condensation and increased binding affinity of RXRA transcription factor that may reduce protein translation and hence the number of available receptors to bind with drugs, which may trigger underlying mechanisms for opioids addiction. Thus, this study outlines causal relationship between opioids addiction and genetic predisposition in Pakistani population.

Citing Articles

Molecular and Environmental Determinants of Addictive Substances.

Lorek M, Kaminski P, Baszynski J, Tadrowski T, Gorzelanczyk E, Feit J Biomolecules. 2024; 14(11).

PMID: 39595582 PMC: 11592269. DOI: 10.3390/biom14111406.

Gene polymorphism impact on opioid analgesic usage.

Widjaja S, Ichwan M, Chowbay B, Rusdiana , Mardani T, Jayalie V J Adv Pharm Technol Res. 2024; 15(3):135-138.

PMID: 39290537 PMC: 11404436. DOI: 10.4103/JAPTR.JAPTR_69_24.

SNP-based and haplotype-based genome-wide association on drug dependence in Han Chinese.

Xu H, Kang Y, Liang T, Lu S, Xia X, Lu Z BMC Genomics. 2024; 25(1):255.

PMID: 38448893 PMC: 10919046. DOI: 10.1186/s12864-024-10117-4.

Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population.

Bagher A, Hareeri R J Appl Biomed. 2023; 21(3):160-165.

PMID: 37747315 DOI: 10.32725/jab.2023.012.

Genetic susceptibility of opioid receptor genes polymorphism to drug addiction: A candidate-gene association study.

Al-Eitan L, Rababah D, Alghamdi M BMC Psychiatry. 2021; 21(1):5.

PMID: 33402148 PMC: 7786995. DOI: 10.1186/s12888-020-03006-z.

References

Bergen A, KOKOSZKA J, Peterson R, Long J, Virkkunen M, Linnoila M . Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry. 1997; 2(6):490-4. DOI: 10.1038/sj.mp.4000331. View

Kosten T, Kreek M, Ragunath J, KLEBER H . A preliminary study of beta endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts. Life Sci. 1986; 39(1):55-9. DOI: 10.1016/0024-3205(86)90437-6. View

Oertel B, Kettner M, Scholich K, Renne C, Roskam B, Geisslinger G . A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain. J Biol Chem. 2009; 284(10):6530-5. DOI: 10.1074/jbc.M807030200. View

Nestler E . Molecular neurobiology of addiction. Am J Addict. 2001; 10(3):201-17. DOI: 10.1080/105504901750532094. View

Mi H, Muruganujan A, Thomas P . PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 2012; 41(Database issue):D377-86. PMC: 3531194. DOI: 10.1093/nar/gks1118. View

Volkow N, Li T . Drug addiction: the neurobiology of behaviour gone awry. Nat Rev Neurosci. 2004; 5(12):963-70. DOI: 10.1038/nrn1539. View

Cami J, Farre M . Drug addiction. N Engl J Med. 2003; 349(10):975-86. DOI: 10.1056/NEJMra023160. View

Chou W, Wang C, Liu P, Liu C, Tseng C, Jawan B . Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology. 2006; 105(2):334-7. DOI: 10.1097/00000542-200608000-00016. View

Tan E, Tan C, Karupathivan U, Yap E . Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport. 2003; 14(4):569-72. DOI: 10.1097/00001756-200303240-00008. View

10.

Janicki P, Schuler G, Francis D, Bohr A, Gordin V, Jarzembowski T . A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain. Anesth Analg. 2006; 103(4):1011-7. DOI: 10.1213/01.ane.0000231634.20341.88. View

11.

Zhang H, Luo X, Kranzler H, Lappalainen J, Yang B, Krupitsky E . Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet. 2006; 15(6):807-19. PMC: 3164878. DOI: 10.1093/hmg/ddl024. View

12.

Nishizaki S, Boyle A . Mining the Unknown: Assigning Function to Noncoding Single Nucleotide Polymorphisms. Trends Genet. 2016; 33(1):34-45. PMC: 5553318. DOI: 10.1016/j.tig.2016.10.008. View

13.

Nagaya D, Ramanathan S, Ravichandran M, Navaratnam V . A118G mu opioid receptor polymorphism among drug addicts in Malaysia. J Integr Neurosci. 2012; 11(1):117-22. DOI: 10.1142/S0219635212500082. View

14.

Crabbe J . Genetic contributions to addiction. Annu Rev Psychol. 2001; 53:435-62. DOI: 10.1146/annurev.psych.53.100901.135142. View

15.

Bell G, KARAM J, Rutter W . Polymorphic DNA region adjacent to the 5' end of the human insulin gene. Proc Natl Acad Sci U S A. 1981; 78(9):5759-63. PMC: 348853. DOI: 10.1073/pnas.78.9.5759. View

16.

Ng P, Henikoff S . SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31(13):3812-4. PMC: 168916. DOI: 10.1093/nar/gkg509. View

17.

Stuart A, Fiser A, Sanchez R, Melo F, Sali A . Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct. 2000; 29:291-325. DOI: 10.1146/annurev.biophys.29.1.291. View

18.

Crowley J, Oslin D, Patkar A, Gottheil E, DeMaria Jr P, OBrien C . A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet. 2003; 13(3):169-73. DOI: 10.1097/00041444-200309000-00006. View

19.

Sia A, Lim Y, Lim E, Goh R, Law H, Landau R . A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology. 2008; 109(3):520-6. DOI: 10.1097/ALN.0b013e318182af21. View

20.

Hou L, Zhao H . A review of post-GWAS prioritization approaches. Front Genet. 2013; 4:280. PMC: 3856625. DOI: 10.3389/fgene.2013.00280. View